Daily Archives: May 21, 2019
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Treated with SGLT2 Inhibitors
21 May, 2019 | 20:19h | UTCCommentary: Recommendations issued for managing SGLT inhibitor-associated DKA risk in type 1 diabetes – Medwire News (free)
Cohort Study: Long-Acting Erythropoietin-Stimulating Agents Linked to Increased Mortality Among Patients Undergoing Hemodialysis
21 May, 2019 | 19:20h | UTCStudy: Long-Acting ESA Users Might Have Worse Survival – Renal & Urology News (free)
Original Article: Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis – Journal of the American Society of Nephrology (link to abstract – $ for full-text)
Review: FDG PET/CT for Assessing Tumor Response to Immunotherapy
21 May, 2019 | 18:50h | UTC
[Abstract Only] Cohort Study: Predictors of Mortality in Patients with Yellow Fever
21 May, 2019 | 19:01h | UTCPredictors of mortality in patients with yellow fever: an observational cohort study – The Lancet Infectious Diseases (link to abstract – $ for full-text)
Related Commentary on Twitter
"Although viral load has not been previously identified as a predictor of death in human beings [due to #YellowFever], we were able to document this association, supporting the idea that there is a direct viral effect on disease pathogenesis" https://t.co/HRXAcUR0Go
— onisillos sekkides ? (@onisillos) May 17, 2019
Acute Flaccid Myelitis: Something Old and Something New
21 May, 2019 | 18:42h | UTCAcute Flaccid Myelitis: Something Old and Something New – mBio (free)
Related: Acute Flaccid Myelitis: A Clinical Overview for 2019 – Mayo Clinic Proceedings (free) AND CDC Investigates Acute Flaccid Myelitis Cases (free study and commentaries)
Review: Neuroimaging in Lewy Body Dementia
21 May, 2019 | 18:34h | UTCNeuroimaging in Lewy body dementia – Journal of Neurology (free)
A Review of Novel Antidepressants: A Guide for Clinicians
21 May, 2019 | 14:56h | UTCA Review of Novel Antidepressants: A Guide for Clinicians – Cureus (free)
Consensus Statement: Treatment of Paroxysmal Nocturnal Hemoglobinuria
21 May, 2019 | 14:54h | UTC
ASA Policy Statement: Recommendations for the Establishment of Stroke Systems of Care
21 May, 2019 | 13:43h | UTCNews Release: New recommendations for stroke systems of care to improve patient outcomes (free)
Meta-Analysis: Laparoscopic vs. Open Liver Resection for Hepatocellular Carcinoma
21 May, 2019 | 13:28h | UTC
Tue May 21 – 10 Stories of The Day!
21 May, 2019 | 06:23h | UTC
#ATS2019 – Highlights from the 2019 Meeting of the American Thoracic Society
1 – Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis – JAMA (free for a limited period)
Editorial: New Phenotypes for Sepsis: The Promise and Problem of Applying Machine Learning and Artificial Intelligence in Clinical Research (free for a limited period)
Commentary: Big data reveals hidden subtypes of sepsis – University of Pittsburgh (free)
Just Presented at the 2019 Meeting of the American Thoracic Society.
2 – Early Sedation with Dexmedetomidine in Critically Ill Patients – New England Journal of Medicine (link to abstract – $ for full-text)
Just Presented at the 2019 Meeting of the American Thoracic Society.
3 – Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Sedation and controlled paralysis do not improve survival of ICU patients with ARDS – University of Pittsburgh (free)
Just Presented at the 2019 Meeting of the American Thoracic Society.
4 – Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Treatment Changes for Mild Asthma? – NEJM Journal Watch (free)
Just Presented at the 2019 Meeting of the American Thoracic Society.
5 – Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Large portion of patients with mild persistent asthma and low sputum eosinophils respond equally well to inhaled corticosteroids as placebo – NIH News Releases (free)
Just Presented at the 2019 Meeting of the American Thoracic Society.
6 – Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Nintedanib slows lung function decline in SSc-associated interstitial lung disease – Medicine Matters (free)
Just Presented at the 2019 Meeting of the American Thoracic Society.
7 – Google’s AI improves accuracy of lung cancer diagnosis, study shows – STAT (free)
See also: A.I. Took a Test to Detect Lung Cancer. It Got an A. – The New York Times (10 articles per month are free)
Original Article: End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography – Nature Medicine (link to abstract – $ for full-text)
8 – Viewpoint: Millions Take Gabapentin for Pain. But There’s Scant Evidence It Works. – The New York Times (10 articles per month are free)
Related: Meta-Analysis: Anticonvulsants in the Treatment of Low Back Pain and Lumbar Radicular Pain (free) AND Benefits and safety of gabapentinoids in chronic low back pain (free) AND Less is More: A Clinical Overview of Off-label Use of Gabapentinoid Drugs (link to abstract)
9 – Viewpoint: Artificial Intelligence in Health Care: Will the Value Match the Hype? – JAMA (free for a limited period)
10 – SCAI clinical expert consensus statement on the classification of cardiogenic shock – Catheterization Cardiovascular Interventions (free) (via @paomorejon)
Commentaries: SCAI releases multi-society endorsed consensus on the classification stages of cardiogenic shock – Society for Cardiovascular Angiography and Interventions (free) AND SCAI Clinical Expert Consensus Statement on Cardiogenic Shock – American College of Cardiology (free)
“Endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019”
#ATS2019 – Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma
21 May, 2019 | 06:16h | UTCControlled Trial of Budesonide–Formoterol as Needed for Mild Asthma – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Treatment Changes for Mild Asthma? – NEJM Journal Watch (free)
Just Presented at the 2019 Meeting of the American Thoracic Society.
#ATS2019 – Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
21 May, 2019 | 06:21h | UTCDerivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis – JAMA (free for a limited period)
Editorial: New Phenotypes for Sepsis: The Promise and Problem of Applying Machine Learning and Artificial Intelligence in Clinical Research (free for a limited period)
Commentary: Big data reveals hidden subtypes of sepsis – University of Pittsburgh (free)
Just Presented at the 2019 Meeting of the American Thoracic Society.
#ATS2019 – Randomized Trial: Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
21 May, 2019 | 06:13h | UTCNintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Nintedanib slows lung function decline in SSc-associated interstitial lung disease – Medicine Matters (free)
Just Presented at the 2019 Meeting of the American Thoracic Society.
#ATS2019 – [Abstract Only] Randomized Trial: Early Sedation with Dexmedetomidine Not Helpful in Critically Ill Patients
21 May, 2019 | 06:19h | UTCEarly Sedation with Dexmedetomidine in Critically Ill Patients – New England Journal of Medicine (link to abstract – $ for full-text)
Just Presented at the 2019 Meeting of the American Thoracic Society.
#ATS2019 – Randomized Trial: Early Neuromuscular Blockade Do Not Benefit Patients with Acute Respiratory Distress Syndrome
21 May, 2019 | 06:18h | UTCEarly Neuromuscular Blockade in the Acute Respiratory Distress Syndrome – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Sedation and controlled paralysis do not improve survival of ICU patients with ARDS – University of Pittsburgh (free)
Just Presented at the 2019 Meeting of the American Thoracic Society.
Related Commentary on Twitter
This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in patients with acute respiratory distress syndrome (ARDS). See the results of the new trial: https://t.co/lcLOUirsOM #ATS2019
— NEJM (@NEJM) May 19, 2019
#ATS2019 – Randomized Trial: Patients with Mild Asma and Low Sputum Eosinophil Levels Do Not Benefit from Inhaled Corticosteroids
21 May, 2019 | 06:15h | UTCMometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Large portion of patients with mild persistent asthma and low sputum eosinophils respond equally well to inhaled corticosteroids as placebo – NIH News Releases (free)
Just Presented at the 2019 Meeting of the American Thoracic Society.
Google’s AI Improves Accuracy of Lung Cancer Diagnosis, Study Shows
21 May, 2019 | 06:10h | UTCGoogle’s AI improves accuracy of lung cancer diagnosis, study shows – STAT (free)
See also: A.I. Took a Test to Detect Lung Cancer. It Got an A. – The New York Times (10 articles per month are free)
Original Article: End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography – Nature Medicine (link to abstract – $ for full-text)
Viewpoint – “Millions Take Gabapentin for Pain. But There’s Scant Evidence It Works.”
21 May, 2019 | 06:04h | UTCMillions Take Gabapentin for Pain. But There’s Scant Evidence It Works. – The New York Times (10 articles per month are free)
Related: Meta-Analysis: Anticonvulsants in the Treatment of Low Back Pain and Lumbar Radicular Pain (free) AND Benefits and safety of gabapentinoids in chronic low back pain (free) AND Less is More: A Clinical Overview of Off-label Use of Gabapentinoid Drugs (link to abstract)
SCAI Clinical Expert Consensus Statement on the Classification of Cardiogenic Shock
21 May, 2019 | 05:59h | UTCSCAI clinical expert consensus statement on the classification of cardiogenic shock – Catheterization Cardiovascular Interventions (free) (via @paomorejon)
Related: Cardiogenic shock: evolving definitions and future directions in management – openheart (free)
Commentaries: SCAI releases multi-society endorsed consensus on the classification stages of cardiogenic shock – Society for Cardiovascular Angiography and Interventions (free) AND SCAI Clinical Expert Consensus Statement on Cardiogenic Shock – American College of Cardiology (free)
“Endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019”
Viewpoint – “Artificial Intelligence in Health Care: Will the Value Match the Hype?”
21 May, 2019 | 06:02h | UTCArtificial Intelligence in Health Care: Will the Value Match the Hype? – JAMA (free for a limited period)